Crystal structure of the human cysteinyl leukotriene receptor 2 in complex with ONO-2080365

Experimental Data Snapshot

  • Resolution: 2.70 Å
  • R-Value Free: 0.246 
  • R-Value Work: 0.194 
  • R-Value Observed: 0.196 

wwPDB Validation   3D Report Full Report

This is version 1.2 of the entry. See complete history


Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors.

Gusach, A.Luginina, A.Marin, E.Brouillette, R.L.Besserer-Offroy, E.Longpre, J.M.Ishchenko, A.Popov, P.Patel, N.Fujimoto, T.Maruyama, T.Stauch, B.Ergasheva, M.Romanovskaia, D.Stepko, A.Kovalev, K.Shevtsov, M.Gordeliy, V.Han, G.W.Katritch, V.Borshchevskiy, V.Sarret, P.Mishin, A.Cherezov, V.

(2019) Nat Commun 10: 5573-5573

  • DOI: https://doi.org/10.1038/s41467-019-13348-2
  • Primary Citation of Related Structures:  
    6RZ6, 6RZ7, 6RZ8, 6RZ9

  • PubMed Abstract: 

    Cysteinyl leukotriene G protein-coupled receptors CysLT 1 and CysLT 2 regulate pro-inflammatory responses associated with allergic disorders. While selective inhibition of CysLT 1 R has been used for treating asthma and associated diseases for over two decades, CysLT 2 R has recently started to emerge as a potential drug target against atopic asthma, brain injury and central nervous system disorders, as well as several types of cancer. Here, we describe four crystal structures of CysLT 2 R in complex with three dual CysLT 1 R/CysLT 2 R antagonists. The reported structures together with the results of comprehensive mutagenesis and computer modeling studies shed light on molecular determinants of CysLTR ligand selectivity and specific effects of disease-related single nucleotide variants.

  • Organizational Affiliation

    Institut de Biologie Structurale Jean-Pierre Ebel, Université Grenoble Alpes-Commissariat à l'Energie Atomique et aux Energies Alternatives-CNRS, Grenoble, France.

Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Cysteinyl leukotriene receptor 2,Soluble cytochrome b562,Cysteinyl leukotriene receptor 2405Homo sapiensEscherichia coliMutation(s): 6 
Membrane Entity: Yes 
UniProt & NIH Common Fund Data Resources
Find proteins for P0ABE7 (Escherichia coli)
Explore P0ABE7 
Go to UniProtKB:  P0ABE7
Find proteins for Q9NS75 (Homo sapiens)
Explore Q9NS75 
Go to UniProtKB:  Q9NS75
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupsP0ABE7Q9NS75
Sequence Annotations
  • Reference Sequence
Small Molecules
Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
KNZ (Subject of Investigation/LOI)
Query on KNZ

Download Ideal Coordinates CCD File 
B [auth A](2~{S})-8-[[4-[4-[2,3-bis(fluoranyl)phenoxy]butoxy]-2-fluoranyl-phenyl]carbonylamino]-4-(4-oxidanyl-4-oxidanylidene-but yl)-2,3-dihydro-1,4-benzoxazine-2-carboxylic acid
C30 H29 F3 N2 O8
Query on OLC

Download Ideal Coordinates CCD File 
C [auth A]
D [auth A]
E [auth A]
F [auth A]
G [auth A]
C [auth A],
D [auth A],
E [auth A],
F [auth A],
G [auth A],
H [auth A],
I [auth A],
J [auth A],
K [auth A],
L [auth A]
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate
C21 H40 O4
Query on OLA

Download Ideal Coordinates CCD File 
M [auth A],
N [auth A],
O [auth A]
C18 H34 O2
Experimental Data & Validation

Experimental Data

  • Resolution: 2.70 Å
  • R-Value Free: 0.246 
  • R-Value Work: 0.194 
  • R-Value Observed: 0.196 
  • Space Group: I 4
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 78.44α = 90
b = 78.44β = 90
c = 172.03γ = 90
Software Package:
Software NamePurpose
XDSdata reduction
XSCALEdata scaling

Structure Validation

View Full Validation Report

Entry History & Funding Information

Deposition Data

Funding OrganizationLocationGrant Number
Russian Science FoundationRussian Federation16-14-10273
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesR35 GM127086
Canadian Institutes of Health ResearchCanada--
Fonds de Recherche du Quebec - Nature et TechnologiesCanada--

Revision History  (Full details and data files)

  • Version 1.0: 2019-12-11
    Type: Initial release
  • Version 1.1: 2019-12-18
    Changes: Database references
  • Version 1.2: 2022-03-30
    Changes: Author supporting evidence, Database references, Derived calculations, Structure summary